KTC
ALBO

Kistler-Tiffany Companies’s Albireo Pharma Inc ALBO Stock Holding History

Kistler-Tiffany Companies’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-500
Closed -$10.8K – 830
2022
Q4 		$10.8K Hold
500
– – ﹤0.01% 616
2022
Q3 		$10K Hold
500
– – ﹤0.01% 604
2022
Q2 		$10K Hold
500
– – ﹤0.01% 591
2022
Q1 		$15K Hold
500
– – ﹤0.01% 562
2021
Q4 		$12K Hold
500
– – ﹤0.01% 579
2021
Q3 		$16K Hold
500
– – ﹤0.01% 536
2021
Q2 		$18K Hold
500
– – ﹤0.01% 505
2021
Q1 		$18K Hold
500
– – ﹤0.01% 474
2020
Q4 		$19K Hold
500
– – 0.01% 438
2020
Q3 		$17K Hold
500
– – 0.01% 413
2020
Q2 		$13K Hold
500
– – ﹤0.01% 422
2020
Q1 		$13K Hold
500
– – ﹤0.01% 414
2019
Q4 		$13K Buy
+500
New +$10K ﹤0.01% 420

Other funds holding ALBO

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Kistler-Tiffany Companies's ALBO Position: Q1 2023 in Review

Kistler-Tiffany Companies sold out of Albireo Pharma Inc (ALBO) in Q1 2023, closing a stake of 500 shares — an estimated $10.8K sold.

Kistler-Tiffany Companies first reported a position in ALBO in Q4 2019 and held it in 13 quarters. The position peaked at $19K in Q4 2020. 3 funds tracked by Wall St. Rank hold ALBO as of Q1 2023.

  • Kistler-Tiffany Companies reported no remaining Albireo Pharma Inc position as of Q1 2023 after selling out during the quarter.
  • Kistler-Tiffany Companies sold 500 Albireo Pharma Inc shares in Q1 2023, an estimated $10.8K.
  • Kistler-Tiffany Companies first reported a position in Albireo Pharma Inc in Q4 2019 and held it in 13 quarters.
  • Kistler-Tiffany Companies's Albireo Pharma Inc position peaked at $19K in Q4 2020.
  • 3 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2023.

Based on Kistler-Tiffany Companies's 13F filing for Q1 2023, filed 3 May 2023.